Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

India · Delayed Price · Currency is INR

180.79

+8.79 (5.11%)

Apr 29, 2026, 3:29 PM IST

14.29% (1Y)

Market Cap	3.44B
Revenue (ttm)	4.46B
Net Income (ttm)	431.20M
Shares Out	19.00M
EPS (ttm)	22.69
PE Ratio	7.97
Forward PE	n/a
Dividend	2.00 (1.16%)
Ex-Dividend Date	Aug 14, 2025

Volume	38,257
Average Volume	37,540
Open	172.01
Previous Close	172.00
Day's Range	171.62 - 181.15
52-Week Range	126.15 - 238.69
Beta	0.57
RSI	72.07
Earnings Date	May 4, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,... [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 1979

Employees 451

Stock Exchange National Stock Exchange of India

Ticker Symbol NATHBIOGEN

Full Company Profile

Financial Performance

In fiscal year 2025, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.70% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.

Financial Statements

News

Nath Bio-Genes (India) Ltd (BOM:537291) Q2 2026 Earnings Call Highlights: Strong Revenue and ...

Nath Bio-Genes (India) Ltd (BOM:537291) Q2 2026 Earnings Call Highlights: Strong Revenue and Profit Growth Amidst Market Challenges

5 months ago - GuruFocus